Resources

Various resources can be found below on sexual and reproductive health and rights (SRHR), sexual and reproductive health (SRH) products, publications published with Concept Foundation or that are useful to anyone looking for more information on the reproductive health (RH) market and community, and information that is relevant to manufacturers of RH products (e.g. information specific to the WHO prequalification procedure).

Temperature stability of oxytocin ampoules labelled for storage at 2°C–8°C and below 25°C: an observational assessment under controlled accelerated and temperature cycling conditions

August 2019

This year, a joint statement issued by WHO/UNICEF/UNFPA recommended the storage of oxytocin between 2-8°C. Nevertheless, certain oxytocin products in the global market are labelled for storage under 25°C.

The Monash Institute of Pharmaceutical Sciences and UNFPA carried out a study to compare the stability of oxytocin injection ampoules formulated for storage at ≤25°C with those labelled for refrigerated storage. The full text can be found here.

WHO consolidated guideline on self-care interventions for health: sexual and reproductive health and rights

2019

The World Health Organization (WHO) uses the following working definition of self-care: Self-care is the ability of individuals, families and communities to promote health, prevent disease, maintain health, and cope with illness and disability with or without the support of a health- care provider.

The purpose of this guideline is to develop a people-centred, evidence-based normative guideline that will support individuals, communities and countries with quality health services and self-care interventions.

Temperature stability of oxytocin ampoules labelled for storage at 2°C–8°C and below 25°C: an observational assessment under controlled accelerated and temperature cycling conditions

August 2019

This year, a joint statement issued by WHO/UNICEF/UNFPA recommended the storage of oxytocin between 2-8°C. Nevertheless, certain oxytocin products in the global market are labelled for storage under 25°C.

The Monash Institute of Pharmaceutical Sciences and UNFPA carried out a study to compare the stability of oxytocin injection ampoules formulated for storage at ≤25°C with those labelled for refrigerated storage. The full text can be found here.

WHO consolidated guideline on self-care interventions for health: sexual and reproductive health and rights

2019

The World Health Organization (WHO) uses the following working definition of self-care: Self-care is the ability of individuals, families and communities to promote health, prevent disease, maintain health, and cope with illness and disability with or without the support of a health- care provider.

The purpose of this guideline is to develop a people-centred, evidence-based normative guideline that will support individuals, communities and countries with quality health services and self-care interventions.

Temperature stability of oxytocin ampoules labelled for storage at 2°C–8°C and below 25°C: an observational assessment under controlled accelerated and temperature cycling conditions

August 2019

This year, a joint statement issued by WHO/UNICEF/UNFPA recommended the storage of oxytocin between 2-8°C. Nevertheless, certain oxytocin products in the global market are labelled for storage under 25°C.

The Monash Institute of Pharmaceutical Sciences and UNFPA carried out a study to compare the stability of oxytocin injection ampoules formulated for storage at ≤25°C with those labelled for refrigerated storage. The full text can be found here.

WHO consolidated guideline on self-care interventions for health: sexual and reproductive health and rights

2019

The World Health Organization (WHO) uses the following working definition of self-care: Self-care is the ability of individuals, families and communities to promote health, prevent disease, maintain health, and cope with illness and disability with or without the support of a health- care provider.

The purpose of this guideline is to develop a people-centred, evidence-based normative guideline that will support individuals, communities and countries with quality health services and self-care interventions.

Every Woman Every Child (May 2016)

This Operational Framework is intended to accompany the 2016-2030 Global Strategy and to serve as a resource for national governments and the wide diversity of stakeholders within countries whose contributions are vital to improving the health and well-being of women, children and adolescents. It offers guidance and options for consideration as countries translate the Global Strategy into national and sub-national strategies and plans, starting with the period 2016-2020. These strategies can – and should – build on existing country-level processes and plans already underway.

Concept Foundation publication on how the work that we do contributes to achieving the SRHR-specific targets within the SDGs (October 2015)